It is now well established that parenteral drug abuse is a significant
risk factor for contracting human immunodeficiency virus type 1 (HIV-
1) infection and subsequently developing AIDS. Earlier studies have sh
own that morphine can modulate various immune responses and therefore
support the premise that morphine is a cofactor in susceptibility to a
nd progression of HIV infection. Dysregulation of interferon (IFN) pro
duction, nonspecific apoptosis of T cells, and the immune response to
soluble HIV gene products have been associated with potential mechanis
ms of pathogenesis in HN disease. The present study was undertaken to
examine the immunomodulatory role of morphine on HN protein-induced ly
mphocyte proliferative responses, Sendai and Newcastle disease virus-i
nduced alpha IFN (IFN-alpha) and IFN-beta production by lymphocytes an
d fibroblast cells, respectively, and induction of apoptosis of normal
lymphocytes in vitro. Our results demonstrate that HN protein-induced
human lymphocyte proliferative responses were significantly inhibited
by morphine in a dose-dependent manner. Furthermore, morphine signifi
cantly inhibited both IFN-alpha and IFN-beta production by normal lymp
hocytes and fibroblasts but induced apoptosis of normal lymphocytes. I
nhibition of IFN-alpha production by morphine could be reversed by the
opiate receptor antagonist naloxone. This suggests that the immunomod
ulatory effects of morphine are mediated through the opioid receptor.
These studies support a role of morphine as a cofactor in the pathogen
esis of HIV infection and describe some of the possible pathologic mec
hanisms which underlie the immunoregulatory effects of morphine.